Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference

Core Insights - Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing therapies for liver and viral diseases [3] - The company will present at the H.C. Wainwright Liver Disease Conference on October 21-22, 2025 [1] - A webcast of the presentation will be available on Aligos' website, with a replay accessible for at least 30 days [2] Company Overview - Aligos Therapeutics aims to improve patient outcomes through best-in-class therapies targeting high unmet medical needs, including chronic hepatitis B virus (HBV) infection and metabolic dysfunction-associated steatohepatitis (MASH) [3] - The company utilizes a science-driven approach and extensive R&D expertise to advance its therapeutic pipeline [3]